Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
Eiji NakamichiHiroki SakakuraShinji MiiNoriyuki YamamotoHideharu HibiMasato AsaiMasahide TakahashiPublished in: Oral diseases (2020)
Serum and salivary exoAlix were identified as potential diagnostic OSCC biomarkers. Serum exoAlix was suitable for prediction of therapeutic responses.